Wednesday, December 7, 2022
wellness India Expo
Home Tags Pharma

Tag: Pharma

Vivek Sehgal appointed the new Director General of OPPI

Vivek Sehgal takes over from KG Ananthakrishnan who has been with OPPI since 2020

Lupin registers net loss of Rs 512 crore in Q4 of...

The company had posted a net profit of Rs 464 crore in the corresponding quarter last fiscal.

HempStreet partners Israel’s Gynica to develop phytopharma products

The partnership is aimed to bolster the combined R&D efforts to improve women’s health with cannabinoid-based phytomedicine

Redcliffe Labs appoints Sanjay Bhargava as its Director M&A & Growth

Bhargava comes with over 30 years of experience across different verticals of healthcare such as pharma, diagnostics, and hospitals

Glenmark receives ‘India Pharma Innovation of the Year’ Award

The prestigious award was conferred upon company by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers for multiple patents and commercialized innovations over the last three years

India needs to ramp up its triple advantage of cost, quality...

S. Aparna emphasized collaboration between large companies and start-ups, industry and academia collaboration by making public research more accessible and collaboration across sectors

Stakeholders must contribute in drafting a 25 year plan for pharma...

7th edition of International Conference on ‘India Pharma & India Medical Device 2022’ kicked-off on 25th April, 2022

P&G Health India hosts the first “Women in Healthcare” Summit

Nearly 1000 participants from 14 leading pharmacy colleges came together with eminent women leaders to learn and discuss opportunities and careers in healthcare

New Delhi to host 7th edition of ‘India Pharma & India...

This conference will decide the roadmap of Indian Pharma and Indian Medical devices sector for the next 25 years to take India beyond ‘Pharmacy of the World'

Glenmark Specialty gets DCGI nod for Phase 1 clinical trial of...

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology